CRISPR Therapeutics CRSP Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's short-term investments?
- CRISPR Therapeutics (CRSP) reported short-term investments of $2.02B in Q1 2026.
- How has CRISPR Therapeutics's short-term investments changed year-over-year?
- CRISPR Therapeutics's short-term investments increased by 24.6% year-over-year, from $1.62B to $2.02B.
- What is the long-term trend for CRISPR Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's short-term investments has grown at a 25.6% compound annual growth rate (CAGR), from $521.71M to $1.63B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.